Apoptosis, excitotoxicity, and neuropathology

Experimental Cell Research

Volumn 239, Issue 2, 1998, Pages 183-201

  Leist, Marcel ^a   Nicotera, Pierluigi ^a  

^a UNIVERSITY OF KONSTANZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EXCITOTOXIN; NITRIC OXIDE; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; BRAIN MITOCHONDRION; CELL DEATH; CELL SURVIVAL; DEGENERATIVE DISEASE; HUMAN; NERVE CELL NECROSIS; NEUROPATHOLOGY; NEUROTOXICITY; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0031816414     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1997.4026     Document Type: Review

References (303)

1. Searle J., Kerr J. F. R., Bishop C. J. Necrosis and apoptosis: Distinct modes of cell death with fundamentally different significance. Pathol. Ann. 17:1982;229-259.
2. Wyllie A. H., Kerr J. F., Currie A. R. Cell death: The significance of apoptosis. Int. Rev. Cytol. 68:1980;251-306.
3. Kerr J. F., Wyllie A. H., Currie A. R. Apoptosis: A basic biological phenomenon with wide ranging implications in tissue kinetics. Br. J. Cancer. 26:1972;239-247.
4. Vanags D. M., Pörn-Ares M. I., Coppola S., Burgess D. H., Orrenius S. Protease involvement in fodrin cleavage and phosphatidylserine exposure in apoptosis. J. Biol. Chem. 271:1996;31075-31085.
5. Fadok V. A., Voelker D. R., Campbell P. A., Cohen J. J., Bratton D. L., Henson P. M. Particle digestibility is required for induction of the phosphatidylserine recognition mechanism used by murine macrophages to phagocytose apoptotic cells. J. Immunol. 148:1992;2207-2216.
6. Martin S. J., Reutelingsperger C. P. M., McGahon A. J., Rader J. A., van Schie R. C. A. A., LaFace D. M., Green D. R. Early redistribution of plasma membrane phoshatidylserine is a general feature of apoptosis regardless of the initiating stimulus: Inhibition by overexpressing of Bcl-2 and Abl. J. Exp. Med. 182:1995;1545-1556.
7. Martin S. J., Finucane D. M., Amarante-Mendes G. P., O'Brien G. A., Green D. R. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J. Biol. Chem. 271:1996;28753-28756.
8. Walker P. R., Kokileva L., LeBlanc J., Sikorska M. Detection of the initial stages of DNA fragmentation in apoptosis. BioTechniques. 15:1993;1032-1040.
9. Oberhammer F., Wilson J. W., Dive C., Morris I. D., Hickman J. A., Wakeling A. E., Walker P. R., Sikorska M. Apoptotic death in epithelial cells: Cleavage of DNA to 300 and/or 50 kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J. 12:1993;3679-3684.
10. Wyllie A. H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 284:1980;555-556.
11. Schwartz L. M., Osborne B. A. Programmed cell death, apoptosis and killer genes. Immunol. Today. 14:1993;582-590.
12. Savill J., Fadok V., Henson P., Haslett C. Phagocyte recognition of cells undergoing apoptosis. Immunol. Today. 14:1993;131-136.
13. Nicholls D., Attwell D. The release and uptake of excitatory amino acids. Trends Pharmacol. Sci. 11:1990;462-468.
14. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S. A. Apoptosis and necrosis: Two distinct events induced respectively by mild and intense insults with NMDA or nitric oxide/superoxide in cortical cell cultures. Proc. Natl. Acad. Sci. USA. 92:1995;72,162-72,166.
15. Ankarcrona M., Dypbukt J. M., Bonfoco E., Zhivotovsky B., Orrenius S., Lipton S. A., Nicotera P. Glutamate-induced neuronal death: A succession of necrosis or apoptosis depending on mitochondrial function. Neuron. 15:1995;961-973.
16. Choi D. W. Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci. 18:1995;58-60.
17. Portera-Cailliau C., Price D. L., Martin L. J. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol. 378:1997;70-87.
18. Portera-Cailliau C., Price D. L., Martin L. J. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: Further evidence for an apoptosis-necrosis continuum. J. Comp. Neurol. 378:1997;88-104.
19. Villalba M., Bockaert J., Journot L. Concomitant induction of apoptosis and necrosis in cerebellar granule cells following serum and potassium withdrawal. NeuroReport. 8:1997;981-985.
20. +. Mol. Pharmacol. 51:1997;542-550.
21. Shimizu S., Eguchi Y., Kamiike W., Itoh Y., Hasegawa J., Yamabe K., Otsuki Y., Matsuda H., Tsujimoto Y. Induction of apoptosis as well as necrosis by hypoxia and predominant prevention of apoptosis by Bcl-2 and Bcl-xL. Cancer Res. 56:1996;2161-2166.
22. Shimizu S., Eguchi Y., Kamiike W., Waguri S., Uchiyama Y., Matsuda H., Tsujimoto Y. Retardation of chemical hypoxia-induced necrotic cell death by Bcl-2 and ICE inhibitors: Possible involvement of common mediators in apoptotic and necrotic signal transductions. Oncogene. 12:1996;2045-2050.
23. Pang Z., Geddes J. W. Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: Acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17:1997;3064-3073.
24. Portera-Cailliau C., Hedreen J. C., Price D. L., Koliatsos V. E. Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models. J. Neurosci. 15:1995;3775-3787.
25. Charriaut-Marlangue C., Aggoun-Zouaoui D., Represa A., Ben-Ari Y. Apoptotic features of selective neuronal death in ischemia, epilepsy and gp120 toxicity. Trends Neurosci. 19:1996;109-114.
26. Leist M., Gantner F., Bohlinger I., Tiegs G., Germann P. G., Wendel A. Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am. J. Pathol. 146:1995;1220-1234.
27. Sloviter R. S., Dean E., Sollas A. L., Goodman J. H. Apoptosis and necrosis induced in different hippocampal neuron populations by repetitive perforant path stimulation in the rat. J. Comp. Neurol. 366:1996;516-533.
28. Charriaut-Marlangue C., Margaill I., Borrega F., Plotkine M., Ben-Ari Y. NG-Nitro-L. Eur. J. Pharmacol. 310:1996;137-140.
29. Linnik M. D., Miller J. A., Sprinkle-Cavallo J., Mason P. J., Thompson F. Y., Montgomery L. R., Schroeder K. K. Apoptotic DNA fragmentation in the rat cerebral cortex induced by permanent middle cerebral artery occlusion. Mol. Brain Res. 32:1995;116-124.
30. Li Y., Chopp M., Jiang N., Yao F., Zaloga C. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J. Cerebr. Blood Flow Metabol. 15:1995;389-397.
31. Li Y., Chopp M., Jiang N., Zaloga C. In situ detection of DNA fragmentation after focal cerebral ischemia in mice. Mol. Brain Res. 28:1995;164-168.
32. Li Y., Chopp M., Jiang N., Zhang Z. G., Zaloga C. Induction of DNA fragmentation after 10 to 120 minutes of focal cerebral ischemia in rats. Stroke. 26:1995;1252-1258.
33. Li Y., Sharov V. G., Jiang N., Zaloga C., Sabbah H. N., Chopp M. Ultrastructural and light microscopic evidence of apoptosis after middle cerebral artery occlusion in the rat. Am. J. Pathol. 146:1995;1045-1051.
34. Beilharz E. J., Williams C. E., Dragunow M., Sirimanne E. S., Gluckman P. D. Mechanisms of delayed cell death following hypoxic-ischemic injury in the immature rat: Evidence for apoptosis during selective neuronal loss. Mol. Brain Res. 29:1995;1-14.
35. Leist M., Nicotera P. The shape of cell death. Biochem. Biophys. Res. Commun. 236:1997;1-9.
36. Dypbukt J. M., Ankarcrona M., Burkitt M., Sjöholm A., Ström K., Orrenius S., Nicotera P. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. J. Biol. Chem. 269:1994;30,533-30,560.
37. Leist M., Single B., Castoldi A. F., Kühnle S., Nicoteram P. Intracellular adenosine triphosphate (ATP) concentration: A switch in the decision between apoptosis and necrosis. J. Exp. Med. 185:1997;1481-1486.
38. D'Souza S. D., Bonetti B., Balasingam V., Cashman N. R., Barker P. A., Troutt A. B., Raine C. S., Antel J. P. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:1996;2361-2370.
39. Künstle G., Leist M., Uhlig S., Revesz L., Feifel R., MacKenzie A., Wendel A. ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or TNF-alpha. Immunol. Lett. 55:1997;5-10.
40. 2+. J. Biol. Chem. 261:1986;14,628-14,635.
41. Ruggiero V., Johnson S. E., Baglioni C. Protection from tumor necrosis factor cytotoxicity by protease inhibitors. Cell. Immunol. 107:1987;317-325.
42. Jacobson M. D., Burne J. F., Raff M. C. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J. 13:1994;1899-1910.
43. Subramanian T., Tarodi B., Chinnadurai G. p53-independent apoptotic and necrotic cell deaths induced by adenovirus infection: Suppression by E1B 19K and Bcl-2 proteins. Cell Growth Differ. 6:1995;131-137.
44. Kane D. J., Örd T., Anton R., Bredesen D. E. Expression of bcl-2 inhibits necrotic neuronal cell death. J. Neurosci. Res. 40:1995;269-275.
45. Zhong L.-T., Sarafian T., Kane D. J., Charles A. C., Mah S. P., Edwards R. H., Bredesen D. E. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc. Natl. Acad. Sci. USA. 90:1993;4533-4537.
46. Lindenboim L., Haviv R., Stein R. Inhibition of drug-induced apoptosis by survival factors in PC12 cells. J. Neurochem. 64:1995;1054-1063.
47. Vaux D. L., Whitney D., Weissman I. L. Activation of physiological cell death mechanisms by a necrosis-causing agent. Microsc. Res. Tech. 34:1996;259-266.
48. Nicotera P., Leist M. Energy supply and the shape of death in neurons and lymphoid cells. Cell Death. Differ. 4:1997;435-442.
49. Lipton S. A., Nicotera P. Neuronal apoptosis. Neuroscientist. 1997.
50. Hirsch T., Marchetti P., Susin S. A., Dallaporta B., Zamzami N., Marzo I., Geuskens M., Kroemer G. The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene. 15:1997;1573-1581.
51. Sarin A., Williams M. S., Alexander-Miller M. A., Berzofsky J. A., Zacharchuk C. M., Henkart P. A. Target cell lysis by CTL granule exocytosis is independent of ICE/Ced-3 family proteases. Immunity. 6:1997;209-215.
52. Xiang J., Chao D. T., Korsmeyer S. J. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1997;14,559-14,563.
53. Dimmeler S., Haendeler J., Nehls M., Zeiher A. M. Suppression of apoptosis by nitric oxide via inhibition of interleukin-1beta-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. Exp. Med. 185:1997;601-607.
54. Melino G., Bernassola F., Knight R. A., Corasaniti M. T., Nistico G., Finazzi-Agro A. S-nitrosylation regulates apoptosis. Nature. 388:1997;432-433.
55. Thompson C. B. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
56. Blaschke A. J., Staley K., Chun J. Widespread programmed cell death in proliferative and postmitotic regions of the featal cerebral cortex. Development. 122:1996;1165-1174.
57. Brown D. R., Schmidt B., Kretzschmar H. A. Role of microglia and host prion protein in neurotoxicity of a prion protein fragment. Nature. 380:1996;345-347.
58. Mattson M. P., Rydel R. E. Amyloid ox-tox transductors. Nature. 382:1996;674-675.
59. Giulian D., Haverkamp L. J., Yu J. H., Karshin W., Tom D., Li J., Kirkpatrick J., Kuo Y.-M., Roher A. E. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J. Neurosci. 16:1996;6021-6037.
60. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J., Migheli A., Nawroth P., Stern D., Schmidt A. M. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 382:1996;685-691.
61. Raff M. C., Barres B. A., Burne J. F., Coles H. S., Ishizaki Y., Jacobson M. D. Programmed cell death and the control of cell survival: Lessons from the nervous system. Science. 262:1993;695-700.
62. Barres B. A., Hart I. K., Coles H. S. R., Burne J. F., Voyvodic J. T., Richardson W. D., Raff M. C. Cell death and control of cell survival in the oligodendrocyte lineage. Cell. 70:1992;31-46.
63. Eitan S., Schwartz M. A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science. 261:1993;106-108.
64. Eitan S., Solomon A., Lavie V., Yoles E., Hirschberg D. L., Belkin M., Schwartz M. Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science. 264:1994;1764-1768.
65. Eizenberg O., Faber-Elman A., Gottlieb E., Oren M., Rotter V., Schwartz M. Direct involvement of p53 in programmed cell death of oligodendrocytes. EMBO J. 14:1995;1136-1144.
66. Patterson P. H. Cytokines in Alzheimer's disease and multiple sclerosis. Curr. Opin. Neurobiol. 5:1995;642-646.
67. Lassmann H., Bancher C., Breitschopf H., Wegiel J., Bobinski M., Jellinger K., Wisniewski H. M. Cell death in Alzheimer's disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:1995;35-41.
68. Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. D., Chao M. V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-720.
69. McLaurin J., D'Souza S., Stewart J., Blain M., Beaudet A., Nalbantoglu J., Antel J. P. Effect of tumor necrosis factor alpha and beta on human oligodendrocytes and neurons in culture. Int. J. Dev. Neurosci. 13:1995;369-381.
70. Louis J.-C., Magal E., Takayama S., Varon S. CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science. 259:1993;689-692.
71. Zajicek J. P., Wing M., Scolding N. J., Compston D. A. S. Interactions between oligodendrocytes and microglia. A major role for complement and tumour necrosis factor in oligodendrocyte adherence and killing. Brain. 115:1992;1611-1631.
72. Hisahara S., Shoji S., Okano H., Miura M. ICE/CED-3 family executes oligodendrocyte apoptosis by tumor necrosis factor. J. Neurochem. 69:1997;10-20.
73. Dowling P., Shang G., Raval S., Menonna J., Cook S., Husar W. Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J. Exp. Med. 184:1996;1513-1518.
74. Dowling P., Husar W., Menonna J., Donnenfeld H., Cook S., Sidhu M. Cell death and birth in multiple sclerosis brain. J. Neurol. Sci. 149:1997;1-11.
75. Bonetti B., Raine C. S. Multiple sclerosis: Oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis. Ann. Neurol. 42:1997;74-84.
76. Oka A., Belliveau M. J., Rosenberg P. A., Volpe J. J. Vulnerability of oligodendroglia to glutamate: Pharmacology, mechanisms, and prevention. J. Neurosci. 13:1993;1441-1453.
77. Hooper D. C., Bagasra O., Marini J. C., Zborel A., Ohnishi S. T., Kean R., Champion J. M., Sarker A. B., Bobroski L., Farber J. L., Akaike T., Maeda H., Koprowski H. Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite: Implications for the treatment of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 94:1997;2528-2533.
78. Merrill J. E., Ignarro L. J., Sherman M. P., Melinek J., Lane T. E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
79. Vartanian T., Li Y., Zhao M., Stefansson K. Interferon-gamma-induced oligodendrocyte cell death: Implications for the pathogenesis of multiple sclerosis. Mol. Med. 1:1995;732-743.
80. Larocca J. N., Farooq M., Norton W. T. Induction of oligodendrocyte apoptosis by C2-ceramide. Neurochem. Res. 22:1997;529-534.
81. Dowling P., Husar W., Menonna J., Donnenfeld H., Cook S., Sidhu M. Cell death and birth in multiple sclerosis brain. J. Neurol. Sci. 149:1997;1-11.
82. Gold R., Hartung H., Lassmann H. T-cell apoptosis in autoimmune diseases: Termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 20:1997;399-404.
83. Schmied M., Breitschopf H., Gold R., Zischler H., Rothe G., Wekerle H., Lassmann H. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis. Evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:1993;446-452.
84. Saas P., Walker P. R., Hahne M., Quiquerez A. L., Schnuriger V., Perrin G., French L., Van Meir E. G., de Tribolet N., Tschopp J., Dietrich P. Y. Fas ligand expression by astrocytoma in vivo: Maintaining immune privilege in the brain? J. Clin. Invest. 99:1997;1173-1181.
85. Green D. R., Ware C. F. Fas-ligand: Privilege and peril. Proc. Natl. Acad. Sci. USA. 94:1997;5986-5990.
86. De Maria R., Lenti L., Malisan F., d'Agostino F., Tomassini B., Zeuner A., Rippo M. R., Testi R. Requirement for GD3 ganglioside in CD95- and ceramide-induced apoptosis. Science. 277:1997;1652-1655.
87. Ziv N. E., Spira M. E. Localized and transient elevations of intracellular Ca2+ induce the dedifferentiation of axonal segments into growth cones. J. Neurosci. 17:1997;3568-3579.
88. Ong W. Y., Garey L. J., Tan K. K. An immunocytochemical study of calpain II in the hippocampus of rats injected with kainate. Exp. Brain Res. 113:1997;117-129.
89. Maxwell W. L., Povlishock J. T., Graham D. L. A mechanistic analysis of non-disruptive axonal injury: A review. J. Neurotrauma. 14:1997;419-440.
90. Dubois-Dauphin M., Frankowski H., Tsujimoto Y., Huarte J., Martinou J. C. Neonatal motoneurons overexpressing the bcl-2 protooncogene in transgenic mice are protected from axotomy-induced cell death. Proc. Natl. Acad. Sci. USA. 91:1994;3309-3313.
91. Smeyne R. J., Vendrell M., Hayward M., Baker S. J., Miao G. G., Schilling K., Robertson L. M., Curran T., Morgan J. I. Continuous c-fos expression precedes programmmed cell death in vivo. Nature. 363:1993;166-169.
92. Sagot Y., Dubois-Dauphin M., Tan S. A., de Bilbao F., Aebischer P., Martinou J. C., Kato A. C. Bcl-2 overexpression prevents motoneuron cell body loss but not axonal degeneration in a mouse model of a neurodegenerative disease. J. Neurosci. 15:1995;7727-7733.
93. Ekström P. A. R. Neurons and glial cells of the mouse sciatic nerve undergo apoptosis after injury in vivo and in vitro. NeuroReport. 6:1995;1029-1032.
94. Berkelaar M., Clarke D. B., Wang Y. C., Bray G. M., Aguayo A. J. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J. Neurosci. 14:1994;4368-4374.
95. Oppenheim R. W., Houenou L. J., Johnson J. E., Lin L.-F. H., Li L., Lo A. C., Newsome A. L., Prevette D. M., Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature. 373:1995;344-346.
96. Beutner G., Rück A., Riede B., Welte W., Brdiczka D. Complexes between kinases, mitochondrial porin, and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett. 396:1996;189-195.
97. Wilson J. E. An introduction to the isoenzymes of mammalian hexokinase types I-III. Biochem. Soc. Trans. 25:1997;103-107.
98. Gellerich F. N. The role of adenylate kinase in dynamic compartmentation of adenine nucleotides in the mitochondrial intermembrane space. FEBS Lett. 297:1992;55-58.
99. 2+. Cell Death Differ. 4:1997;317-324.
100. Ellerby H. M., Martin S. J., Ellerby L. M., Naiem S. S., Rabizadeh S., Salvesen G. S., Casiano C. A., Cashman N. R., Green D. R., Bredesen D. E. Establishment of a cell-free system of neuronal apoptosis: Comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17:1997;6165-6178.
101. Lipton S. A., Rosenberg P. A. Excitatory amino acids as a final common pathway for neurologic disorders. New Engl. J. Med. 330:1994;613-622.
102. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 15:1996;5795-5811.
103. Kim T.-W., Pettingell W. H., Jung Y.-K., Kovacs D. M., Tanzi R. E. Alternative cleavage of Alzheimer-associated presenilins during apoptosis by a caspase-3 family protease. Science. 277:1997;373-375.
104. Aguzzi A., Weissmann C. Prion research: The next frontiers. Nature. 389:1996;795-798.
105. Goldberg Y. P., Nicholson D. W., Rasper D. M., Kalchman M. A., Koide H. B., Graham R. K., Bromm M., Kazemi-Esfarjani P., Thornberry N. A., Vaillancourt J. P., Hayden M. R. Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13:1996;442-449.
106. Beal M. F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6:1996;661-666.
107. Beal, M. F. Hyman, B. T. Koroshetz, W. 1993, Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases?, Trends Neurosci., 16, 125, 131.
108. Wallace D. C., Shoffner J. M., Trounce I., Brown M. D., Ballinger S. W., Corral-Debrinski M., Horton T., Jun A. S., Lott M. T. Mitochondrial DNA mutations in human degenerative diseases and aging. Biochim. Biophys. Acta. 1271:1995;141-151.
109. Ozawa T., Hayakawa M., Katsumata K., Yoneda M., Ikebe S.-I., Mizuno Y. Fragile mitochondrial DNA: The missing link in the apoptotic neuronal cell death in Parkinson's disease. Biochem. Biophys. Res. Commun. 235:1997;158-161.
110. Schinder A. F., Olson E. C., Spitzer N. C., Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:1996;6125-6133.
111. White R. J., Reynolds I. J. Mitochondiral depolarization in glutamate-stimulated neurons: An early signal specific to excitotoxin exposure. J. Neurosci. 16:1996;5688-5697.
112. Ankarcrona M., Dypbukt J. M., Orrenius S., Nicotera P. Calcineurin and mitochondrial function in glutamate-induced neuronal cell death. FEBS Lett. 394:1996;321-324.
113. Dugan L. L., Sensi S. L., Canzoniero L. M. T., Handran S. D., Rothman S. M., Lin T.-S., Goldberg M. P., Choi D. W. Mitochondrial production of reactive oxygen species in cortical neurons following exposure toND. J. Neurosci. 15:1995;6377-6388.
114. Reynolds I. J., Hastings T. G. Glutamate induces the production of reactive oxygen species in cultured forebrain neurons following NMDA receptors activation. J. Neurosci. 15:1995;3318-3327.
115. 2++. J. Neurochem. 63:1994;584-591.
116. Du Y., Bales K. R., Dodel R. C., Hamilton-Byrd E., Horn J. W., Czilli D. L., Simmons L. K., Ni B., Paul S. M. Activation of a caspase 3-related cysteine protease is required for glutamate-mediated apoptosis of cultured cerebellar granule neurons. Proc. Natl. Acad. Sci. USA. 94:1997;11,657-11,662.
117. Leist M., Volbracht C., Kühnle S., Fava E., Ferrando-May E., Nicotera P. Caspase-mediated apoptosis in neuronal excitotoxicity triggered by nitric oxide. Mol. Med. 3:1997;750-764.
118. Golstein P. Controlling cell death. Science. 275:1997;1081-1082.
119. Boise L. H., Thompson C. B. Bcl-xl can inhibit apoptosis in cells that have undergone fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:1997;3759-3764.
120. Xiang J., Chao D. T., Korsmeyer S. J. BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:1997;14,559-14,563.
121. Woodle E. S., Smith D. M., Bluestone J. A., Kirkman W. M. III, Green D. R., Skowronski E. W. Anti-human class I MHC antibodies induce apoptosis by a pathway that is distinct from the Fas antigen-mediated pathway. J. Immunol. 158:1997;2156-2164.
122. McCarthy N. J., Whyte M. K. B., Gilbert C. S., Evan G. I. Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the bcl-2 homologue bak. J. Cell. Biol. 136:1997;215-227.
123. Miossec C., Dutilleul V., Fassy F., Diu-Hercend A. Evidence for CPP32 activation in the absence of apoptosis during T lymphocyte stimulation. J. Biol. Chem. 272:1997;13,459-13,462.
124. Barrett G. L., Bartlett P. F. The p75 nerve growth factor receptor mediates survival or death depending on the stage of sensory neuron development. Proc. Natl. Acad. Sci. USA. 91:1994;6501-6505.
125. Frade J. M., Rodríguez-Tébar A., Barde Y.-A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature. 383:1996;166-168.
126. Rabizadeh S., Oh J., Zhong L.-T., Yang J., Bitler C. M., Butcher L. L., Bredesen D. E. Induction of apoptosis by the low-affinity NGF receptor. Science. 261:1993;345-348.
127. Molinari M., Carafoli E. Calpain: A cytosolic proteinase active at the membranes. J. Membr. Biol. 156:1997;1-8.
128. Squier M. K. T., Miller A. C. K., Malkinson A. M., Cohen J. J. Calpain activation in apoptosis. J. Cell. Physiol. 159:1994;229-237.
129. Nath R., Raser K. J., Stafford D., Hajimohammadreza I., Rosner A., Allen H., Talanian R. V., Yuen P., Gilbertsen R. B., Wang K. K. W. Non-erythroid alpha-spectin breakdown by calpain and interleukin 1beta-converting-enzyme-like protease(s) in apoptotic cells: Contributory roles of both protease families in neuronal apoptosis. Biochem. J. 319:1996;683-690.
130. Wang K. K. W., Yuen P.-W. Development and therapeutic potential of calpain inhibitors. Adv. Pharmacol. 37:1997;117-153.
131. Saido T. C., Sorimachi H., Suzuki K. Calpain: New perspectives in molecular diversity and physiological-pathological involvement. FASEB J. 8:1994;814-822.
132. Stefanis L., Troy C. M., Qi H., Greene L. A. Inhibitors of trypsin-like serine proteases inhibit processing of the caspase Nedd-2 and protect PC12 cells and sympathetic neurons from death evoked by withdrawal of trophic support. J. Neurochem. 69:1997;1425-1437.
133. Leist M., Nicotera P. Calcium and neuronal death. Rev. Physiol. Pharmacol. Biochem. 132:1997;79-125.
134. Yu S. P., Yeh C., Sensi S. L., Gwag B. J., Canzoniero L. M. T., Farhangrazi Z. S., Ying H. S., Tian M., Dugan L. L., Choi D. W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science. 278:1997;114-117.
135. Zhang J., Dawson V. L., Dawson T. M., Snyder S. H. Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science. 263:1994;687-689.
136. Leist M., Fava E., Montecucco C., Nicotera P. Peroxynitrite and NO-donors induce neuronal apoptosis by eliciting autocrine excitotoxicity. Eur. J. Neurosci. 9:1997;1488-1498.
137. Eliasson M. J. L., Sampei K., Mandir A S., Hurn P. D., Traystman R. J., Bao J., Pieper A., Wang Z.-Q., Dawson T. M., Snyder S. H., Dawson V. L. Poly(ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia. Nature Med. 3:1997;1089-1095.
138. Wang Z.-Q., Auer B., Stingl L., Berghammer H., Haidacher D., Schweiger M., Wagner E. F. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease. Genes Dev. 9:1995;509-520.
139. Leist M., Single B., Künstle G., Volbracht C., Hentze H., Nicotera P. Apoptosis in the absence of poly-(ADP-ribose) polymerase. Biochem. Biophys. Res. Commun. 233:1997;518-522.
140. Endres M., Wang Z. Q., Namura S., Waeber C., Moskowitz M. A. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase. J. Cereb. Blood Flow Metab. 17:1997;1143-1153.
141. Allsopp T. E., Wyatt S., Paterson H. F., Davies A. M. The proto-oncogene bcl-2 can selectively rescue neurotrophic factor-dependent neurons from apoptosis. Cell. 73:1993;295-307.
142. Arenas E., Persson H. Neurotrophin-3 prevents the death of adult central noradrenergic neurons in vivo. Nature. 367:1994;368-371.
143. Morrison R. S., Sharma A., de Vellis J., Bradshaw R. A. Basic fibroblast growth factor supports the survival of cerebral cortical neurons in primary culture. Proc. Natl. Acad. Sci. USA. 83:1986;7537-7541.
144. Deckwerth T. L., Johnson E. M. Jr. Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J. Cell Biol. 123:1993;1207-1222.
145. Deckwerth T. L., Elliott J. L., Knudson C. M., Johnson E. M. Jr., Snider W. D., Korsmeyer S. J. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17:1996;401-411.
146. Sendtner M., Schmalbruch H., Stöckli K. A., Carroll P., Kreutzberg G. W., Thoenen H. Ciliary neurotrophic factor prevents degeneration of motor neurons in mouse mutant progressive motor neuronopathy. Nature. 358:1992;502-504.
147. Snider W. D. Functions of the neurotrophins during nervous system development: What the knockouts are teaching us. Cell. 77:1994;627-638.
148. Johnson E. M., Deckwerth T. L. Molecular mechanisms of developmental neuronal death. Annu. Rev. Neurosci. 16:1993;31-46.
149. Martinou J.-C., Dubois-Dauphin M., Staple J. K., Rodriguez I., Frankowski H., Missotten M., Albertini P., Talabot D., Catsicas S., Pietra C., Huarte J. Overexpression of bcl-2 in transgenic mice protects neurons from naturally occuring cell death and experimental ischemia. Neuron. 13:1994;1017-1030.
150. Prehn J. H. M., Bindokas V. P., Marcuccilli C. J., Krajewski S., Reed J. C., Miller R. J. Regulation of neuronal Bcl-2 protein expression and calcium homeostasis by transforming growth factor type beta confers wide-ranging protection on rat hippocampal neurons. Proc. Natl. Acad. Sci. USA. 91:1994;12,599-12,603.
151. Michaelidis T. M., Sendtner M., Cooper J. D., Airaksinen M. S., Holtmann B., Meyer M., Thoenen H. Inactivation of bcl-2 results in progressive degeneration of motoneurons, sympathetic and sensory neurons during early postnatal development. Neuron. 17:1996;75-89.
152. Garcia I., Martinou I., Tsujimoto Y., Martinou J.-C. Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science. 258:1992;302-303.
153. Greenlund L. J. S., Korsmeyer S. J., Johnson E. M. Role of BCL-2 in the survival and function of developing and mature sympathetic neurons. Neuron. 15:1995;649-661.
154. 2+. J. Neurochem. 65:1995;1740-1751.
155. Verity M. A., Bredesen D. E., Sarafian T. Role of reactive oxygen species (ROS) in neuronal degeneration. Modulation by protooncogene expression. Ann. N.Y. Acad. Sci. 765:1995;340.
156. Bredesen D. E. Neural apoptosis. Ann. Neurol. 38:1995;839-851.
157. Kane D. J., Sarafian T. A., Anton R., Hahn H., Gralla E. B., Valentine J. S., Örd T., Bredesen D. E. Bcl-2 inhibition of neural death: Decreased generation of reactive oxygen species. Science. 262:1993;1274-1277.
158. Greenlund L. J. S., Deckwerth T. L., Johnson E. M. Superoxide dismutase delays neuronal apoptosis: A role for reactive oxygen species in programmed neuronal death. Neuron. 14:1995;303-315.
159. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol. Sci. 11:1990;379-387.
160. Choi D. W. Glutamate neurotoxicity and diseases of the nervous system. Neuron. 1:1988;623-634.
161. Drejer J., Beneviste H., Diemer N. H., Schousboe A. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J. Neurochem. 45:1985;145-151.
162. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J. Neurosci. 4:1984;1884-1891.
163. Sandberg M., Butcher S. P., Hagberg H. Extracellular overflow of neuroactive amino acids during severe insulin-induced hypoglycemia: In vivo dialysis of the rat hippocampus. J. Neurochem. 47:1986;178-184.
164. Wieloch T. Hypoglycemia-induced neuronal damage prevented by anND. Science. 230:1985;681-683.
165. +ND. Nature. 349:1991;414-418.
166. Ishimaru H., Katoh A., Suzuki H., Fukuta T., Kameyama T., Nabeshima T. Effects ofND. J. Pharmacol. Exp. Therapeutics. 261:1992;349-352.
167. Bagetta G., Nisticò G., Bowery N. G. Prevention by the NMDA receptor antagonist, of neuronal loss produced by tetanus toxin in the rat hippocampus. Br. J. Pharmacol. 101:1990;776-780.
168. Koh J.-Y., Gwag B. J., Lobner D., Choi D. W. Potentiated necrosis of cultured cortical neurons by neurotrophins. Science. 268:1995;573-575.
169. Beckman J. S., Koppenol W. H. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and the ugly. Am. J. Physiol. 271:1996;C1424-C1437.
170. Garthwaite J., Boulton C. L. Nitric oxide signaling in the central nervous system. Annu. Rev. Physiol. 57:1995;683-706.
171. Zhang J., Snyder S. H. Nitric oxide in the nervous system. Annu. Rev. Pharmacol. Toxicol. 35:1995;213-233.
172. Huang Z., Huang P. L., Panahian N., Dalkara T., Fishman M. C., Moskowitz M. A. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 265:1994;1883-1885.
173. Huang P. L., Fishman M. C. Genetic analysis of nitric oxide synthase isoforms: Targeted mutation in mice. J. Mol. Med. 74:1996;415-421.
174. Sandani A. F., Dawson T. M., Dawson V. L. Nitric oxide synthase in models of focal ischemia. Stroke. 28:1997;1283-1288.
175. Snyder S. H. No NO prevents parkinsonism. Nature Med. 2:1996;965-966.
176. Schulz J. B., Matthews R. T., Jenkins B. G., Ferrante R. J., Siwek D., Henshaw D. R., Cipolloni P. B., Mecocci P., Kowall N. W., Rosen B. R., Beal M. F. Blockade of neuronal nitric oxide synthase protects against excitotoxicity in vivo. J. Neurosci. 15:1995;8419-8429.
177. Schulz J. B., Huang P. L., Matthews R. T., Passov D., Fishman M. C., Beal M. F. Striatal malonate lesions are attenuated in neuronal nitric oxide synthase knockout mice. J. Neurochem. 67:1996;430-433.
178. Galpern W. R., Matthews R. T., Beal F. M., Isacson O. NGF attenuates 3-nitrotyrosine formation in a 3-NP model of Huntington's disease. NeuroReport. 7:1996;2639-2642.
179. Crow J. P., Beckman J. S. Reactions between nitric oxide, superoxide, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv. Pharmacol. 34:1995;17-43.
180. Gross S. S., Wolin M. S. Nitric oxide: Pathophysiological mechanisms. Annu. Rev. Physiol. 57:1995;737-769.
181. Stamler J. S., Simon D. I., Osborne J. A., Mullins M. E., Jaraki O., Michel T., Singel D. J., Loscalzo J. S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA. 89:1992;444-448.
182. Stamler J. S. Redox signaling: Nitrosylation and related target interactions of nitric oxide. Cell. 78:1994;931-936.
183. Stamler J. S., Jia L., Eu J. P., McMahon T. J., Demchenko I. T., Bonaventura J., Gernert K., Piantadosi C. A. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science. 276:1997;2034-2037.
184. Meffert M. K., Premack B. A., Schulman H. Nitric oxide stimulates calcium-independent synaptic vesicle release. Neuron. 12:1994;1235-1244.
185. Meffert M. K., Calakos N. C., Scheller R. H., Schulman H. Nitric oxide modulates synaptic vesicle docking/fusion reactions. Neuron. 16:1996;1229-1236.
186. Lipton S. A., Choi Y.-B., Pan Z.-H., Lei S. Z., Chen H.-S. V., Sucher N. J., Loscalzo J., Singel D. J., Stamler J. S. A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature. 364:1993;626-632.
187. Dawson V. L., Dawson T. M., Bartley D. A., Uhl G. R., Snyder S. H. Mechanisms of nitric oxide-mediated neurotoxicity in primary brain cultures. J. Neurosci. 13:1993;2651-2661.
188. Estévez A. G., Radi R., Barbeito L., Shin J. T., Thompson J. A., Beckman J. S. Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differentially modulated by neurotrophic factors. J. Neurochem. 65:1995;1543-1550.
189. Lin K.-T., Xue J.-Y., Nomen M., Spur B., Wong P. Y.-K. Peroxynitrite-induced apoptosis in HL-60 cells. J. Biol. Chem. 270:1995;16,487-16,490.
190. Troy C. M., Derossi D., Prochiantz A., Greene L. A., Shelanski M. L. Down-regulation of Cu/Zn superoxide dismutase leads to cell death via the nitric oxide-peroxynitrite pathway. J. Neurosci. 18:1996;253-261.
191. Beckmann J. S., Ye Z. Y., Anderson P. G., Chen J., Accavitti M. A., Tarpey M. M., White C. R. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe-Seyler. 375:1994;81-88.
192. Ischiropoulos H., Zhu L., Chen J., Tsai M., Martin J. C., Smith C. D., Beckman J. S. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch. Biochem. Biophys. 298:1992;431-437.
193. Radi R., Beckmann J. S., Bush K. M., Freeman B. A. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J. Biol. Chem. 266:1991;4244-4250.
194. Beckman J. S., Beckman T. W., Chen J., Marshall P. A., Freeman B. A. Apparent hydroxyl radical production by peroxynitrite: Implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1990;1620-1624.
195. Beckman J. S., Chen J., Ischiropoulos H., Crow J. P. Oxidative chemistry of peroxynitrite. Methods Enyzmol. 233:1995;229-240.
196. Bolanos J. P., Heales S. J. R., Land J. M., Clark J. B. Effect of peroxynitrite on the mitochondrial respiratory chain: Differential susceptibility of neurones and astrocytes in primary culture. J. Neurochem. 64:1995;1965-1972.
197. O'Dell T. J., Hawkins R. D., Kandel E. R., Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: Evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. USA. 88:1991;11,285-11,289.
198. Hirsch D. B., Steiner J. P., Dawson T. M., Mammen A., Hayek E., Snyder S. H. Neurotransmitter release regulated by nitric oxide in PC-12 cells and brain synaptosomes. Curr. Biol. 3:1993;749-754.
199. Bonfoco E., Leist M., Zhivotovsky B., Orrenius S., Lipton S. A., Nicotera P. Cytoskeletal breakdown and apoptosis elicited by NO-donors in cerebellar granule cells require NMDA-receptor activation. J. Neurochem. 67:1996;2484-2493.
200. Armstrong R. C., Aja T. J., Hoang K. D., Gaur S, Bai X., Alnemri E., Litwack G., Karanewsky D. S., Fritz L. C., Tomaselli K. J. Activation of the Ced3/ICE-related protease CPP32 in cerebellar granule neurons undergoing apoptosis but not necrosis. J. Neurosci. 17:1997;553-562.
201. Schulz J. B., Weller M., Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons: A sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reative oxygen species. J. Neurosci. 16:1996;4696-4706.
202. Lynch T., Vasilakos J. P., Raser K., Keane K. M., Shivers B. D. Inhibition of the interleukin-1 beta converting enzyme family rescues neurons from apoptotic death. Mol. Psych. 2:1997;227-238.
203. Deshmukh M., Vasilakos J., Deckwerth T. L., Lampe P. A., Shivers B. D., Johnson E. M. Genetic and metabolic status of NGF-deprived sympathetic neurons saved by an inhibitor of ICE family proteases. J. Cell. Biol. 135:1996;1341-1354.
204. Milligan C. E., Prevette D., Yaginuma H., Homma S., Cardwell C., Fritz L. C., Tomaselli K. J., Oppenheim R. W., Schwartz L. M. Peptide inhibitors of the ICE protease family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron. 15:1995;385-393.
205. Srinivasan A., Foster L. M., Testa M.-P., Örd T., Keane R. W., Bredesen D. E., Kayalar C. Bcl-2 expression in neuronal cells blocks activation of ICE/CED-3 family proteases during apoptosis. J. Neurosci. 16:1996;5654-5660.
206. Stefanis L., Park D. S., Yan C. Y. I., Farinelli S. E., Troy C. M., Shelanski M. L., Greene L. A. Induction of CPP32-like activity in PC12 cells by withdrawal of trophic support. Dissociation from apoptosis. J. Biol. Chem. 271:1996;30,663-30,671.
207. Troy C. M., Stefanis L., Prochiantz A., Greene L. A., Shelanski M. L. The contrasting roles of ICE family proteases and interleukin-1beta in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc. Natl. Acad. Sci. USA. 93:1996;5635-5640.
208. Hara H., Friedlander R. M., Gagliardini V., Ayata C., Fink K., Huang Z., Shimizu-Sasamata M., Yuan J., Moskowitz M. A. Inhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. Proc. Natl. Acad. Sci. USA. 94:1997;2007-2012.
209. Loddick S. A., MacKenzie A., Rothwell N. J. An ICE inhibitor, z-VAD-DCB attenuates ischaemic brain damage in the rat. NeuroReport. 7:1996;1465-1468.
210. Hara H., Fink K., Endres M., Friedlander R. M., Gagliardini V., Yuan J., Moskowitz M. Attenuation of transient focal cerebral ischemic injury in transgenic mice expressing a mutant ICE inhibitory protein. J. Cereb. Blood Flow Metab. 17:1997;370-375.
211. Friedlander R. M., Gagliardini V., Rotello R. J., Yuan J. Functional role of interleukin-1β (IL-1β) in IL-1β converting enzyme-mediated apoptosis. J. Exp. Med. 184:1996;717-724.
212. MacManus J. P., Rasquinha I., Black M. A., Laferriere N. B., Monette R., Walker T., Morley P. Glutamate-treated rat cortical neuronal cultures die in a way different from the classical apoptosis induced by staurosporine. Exp. Cell. Res. 233:1997;310-320.
213. Gwag B. J., Lobner D., Koh J. Y., Wie M. B., Choi D. W. Blockade of glutamate receptors unmasks neuronal apoptosis after oxygen-glucose deprivation in vitro. Neuroscience. 68:1995;615-619.
214. Charriaut-Marlangue C., Margaill I., Plotkine M., Ben-Ari Y. Early endonuclease activation following reversible focal ischemia in the rat brain. J. Cereb. Blood Flow Metab. 15:1995;385-388.
215. Pollard H., Charriaut-Marlangue C., Centagrel A., Represa A., Robain O., Moreau J., Ben-Ari Y. Kainate-induced apoptotic cell death in hippocampal neurons. Neuroscience. 63:1994;7-18.
216. Mitchell I. J., Lawson S., Moser B., Laidlaw S. M., Cooper A. J., Walkinshaw G., Waters C. M. Glutamate-induced apoptosis results in a loss of striatal neurons in the parkinsonian rat. Neuroscience. 63:1994;1-5.
217. Kruman I., Bruce-Keller A. J., Bredesen D., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
218. Rink A., Fung K.-M., Trojanowski J. Q., Lee V. M.-Y., Neugebauer E., McIntosh T. K. Evidence of apoptotic cell death after experimental traumatic brain injury in the rat. Am. J. Pathol. 147:1995;1575-1583.
219. Dipasquale B., Marini A. M., Youle R. J. Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem. Biophys. Res. Commun. 181:1991;1442-1448.
220. Deckwerth T. L., Elliott J. L., Knudson C. M., Johnson E. M. Jr, Snider W. D., Korsmeyer S. J. BAX is required for neuronal death after trophic factor deprivation and during development. Neuron. 17:1996;401-411.
221. Krajewski S., Mai J. K., Krajewska M., Sikorska M., Mossakowski M. J., Reed J. C. Upregulation of bax protein levels in neurons following cerebral ischemia. J. Neurosci. 15:1995;6364-6376.
222. Gillardon F., Wickert H., Zimmermann M. Up-regulation of bax and down-regulation of bcl-2 is associated with kainate-induced apoptosis in mouse brain. Neurosci. Lett. 192:1995;85-88.
223. Chen J., Zhu R. L., Nakayama M., Kawaguchi K., Jin K., Stetler R. A., Simon R. P., Graham S. H. Expression of the apoptosis-effector gene, Bax, is up-regulated in vulnerable hippocampal CA1 neurons following global ischemia. J. Neurochem. 67:1996;64-71.
224. Farlie P. G., Dringen R., Rees S. M., Kannourakis G., Bernard O. bcl-2 transgene expression can protect neurons against developmental and induced cell death. Proc. Natl. Acad. Sci. USA. 92:1995;4397-4401.
225. Sakhi S., Bruce A., Sun N., Tosso G., Baudry M., Schreiber S. S. p53 induction is associated with neuronal damage in the central nervous system. Proc. Natl. Acad. Sci. USA. 91:1994;7525-7529.
226. Jordán J., Galindo M. F., Prehn J. H. M., Weichselbaum R. R., Beckett M., Ghadge G. D., Roos R. P., Leiden J. M., Miller R. J. p53 epression induces apoptosis in hippocampal pyramidal neuron cultures. J. Neurosci. 17:1997;1397-1405.
227. Sadoul R., Quiquerez A.-L., Martinou I., Fernandez P. A., Martinou J.-C. p53 protein in sympathetic neurons: Cytoplasmic localization and no apparent function in apoptosis. J. Neurosci. Res. 43:1996;594-601.
228. Morrison R. S., Wenzel H. J., Kinoshita Y., Robbins C. A., Donehower L. A., Schwartzkroin P. A. Loss of the p53 tumor suppressor gene protects neurons from kainate-induced cell death. J. Neurosci. 16:1996;1337-1345.
229. Xiang H., Hochman D. W., Saya H., Fujiwara T., Schwartzkroin P. A., Morrison R. S. Evidence for p53-mediated modulation of neuronal viability. J. Neurosci. 16:1996;6753-6765.
230. Eizenberg O., Faber-Elman A., Gottlieb E., Oren M., Rotter V., Schwartz M. p53 plays a regulatory role in differentiation and apoptosis of central nervous system-associated cells. Mol. Cell. Biol. 16:1996;5178-5185.
231. Kure S., Tominaga T., Yoshimoto T., Tada K., Narisawa K. Glutamate triggers internucleosomal DNA cleavage in neuronal cells. Biochem. Biophys. Res. Commun. 179:1991;39-45.
232. Troy C. M., Shelanski M. L. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc. Natl. Acad. Sci. USA. 91:1994;6384-6387.
233. Ferrari G., Anderson B. L., Stephens R. M., Kaplan D. R., Greene L. A. Prevention of apoptotic neuronal death by GM1 ganglioside: Involvement of Trk neurotrophin receptors. J. Biol. Chem. 270:1995;3074-3080.
234. Mesner P. W., Epting C. L., Hegarty J. L., Green S. H. A timetable of events during programmed cell death induced by trophic factor withdrawal from neuronal PC12 cells. J. Neurosci. 15:1995;7357-7366.
235. Mesner P. W., Winters T. R., Green S. H. Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons. J. Cell. Biol. 119:1992;1669-1680.
236. Mah S. P., Zhong L. T., Liu Y., Roghani A., Edwards R. H., Bredesen D. E. The protooncogene bcl-2 inhibits apoptosis in PC12 cells. J. Neurochem. 60:1993;1183-1186.
237. Yao R., Cooper G. M. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science. 267:1995;2003-2005.
238. Park D. S., Morris E. J., Greene L. A., Geller H. M. G1/S cell cycle blockers and inhibitors of cyclin-dependent kinases suppress camptothecin-induced neuronal apoptosis. J. Neurosci. 17:1997;1256-1270.
239. Morris E. J., Geller H. M. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-independent toxicity. J. Cell. Biol. 134:1996;757-770.
240. Guo Q., Sopher B. L., Furukawa K., Pham D. G., Robinson N., Martin G. M., Mattson M. P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid beta-peptide: Involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
241. Müller W. E. G., Ushijima H., Schröder H. C., Forrest J. M. S., Schatton W. F. H., Rytik P. G., Heffner-Lauc M. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. Eur. J. Pharmacol. 246:1993;261-267.
242. Viviani B., Rossi A. D., Chow S. C., Nicotera P. Organotin compounds induce calcium overload and apoptosis in PC12 cells. Neurol. Toxicol. 16:1995;19-26.
243. Hartley A., Stone J. M., Heron C., Cooper J. M., Schapira A. H. V. Complex I inhibitors induce dose-dependent apoptosis in PC12 cells: Relevance to Parkinson's disease. J. Neurochem. 63:1994;1987-1990.
244. Bonfoco E., Zhivotovsky B., Rossi A. D., Aguillar-Santelises M., Orrenius S., Lipton S. A., Nicotera P. Bcl-2 delays apoptosis and PARP cleavage induced by NO-donors in GT1-7 cells. NeuroReport. 8:1996;273-276.
245. +. J. Neurosci. Res. 48:1997;226-237.
246. Yamatsuji T., Matsui T., Okamoto T., Komatsuzaki K., Takeda S., Fukumoto H., Iwatsubo T., Suzuki N., Asami-Odaka A., Ireland S., Kinane T. B., Giambarella U., Nishimoto I. G protein-mediated neuronal DNA fragmentation induced by familial Alzheimer's disease-associated mutants of APP. Science. 272:1996;1349-1352.
247. Piacentini M., Annicchiarico-Petruzzelli M., Oliverio S., Piredda L., Biedler J. L., Melino G. Phenotype-specific "tissue" transglutaminase regulation in human neuroblastoma cells in response to retinoic acid: Correlation with cell death by apoptosis. Int. J. Cancer. 52:1992;271-278.
248. Kharlamov E., Cagnoli C. M., Atabay C., Ikonomovic S., Grayson D. R., Manev H. Opposite effect of protein synthesis inhibitors on potassium deficiency-induced apoptotic cell death in immature and mature neuronal cultures. J. Neurochem. 65:1995;1395-1398.
249. Kubo T., Nonomura T., Enokido Y., Hatanaka H. Brain-derived neurotrophic factor (BDNF) can prevent apoptosis of rat cerebellar granule neurons in culture. Dev. Brain Res. 85:1995;249-258.
250. D'Mello S., Galli C., Ciotti T., Calissano P. Induction of apoptosis in cerebellar granule neurons by low potassium: Inhibition of death by insulin-like growth factor I and cAMP. Proc. Natl. Acad. Sci. USA. 90:1989;10,989-10,993.
251. Edwards S. N., Buckmaster A. E., Tolkovsky A. M. The death programme in cultured sympathetic neurones can be suppressed at the posttranslational level by nerve growth factor, cyclic AMP, and depolarization. J. Neurochem. 57:1991;2140-2143.
252. Bonfoco E., Ceccatelli S., Manzo L., Nicotera P. Colchicine induces apoptosis in cerebellar granule cells. Exp. Cell Res. 218:1995;189-200.
253. Tanabe H., Eguchi Y., Kamada S., Martinou J.-C., Tsujimoto Y. Susceptibility of cerebellar granule neurons derived from bcl-2-deficient and transgenic mice to cell death. Eur. J. Neurosci. 9:1997;848-856.
254. Ishitani R., Sunaga K., Hirano A., Saunders P., Katsube N., Chuang D.-M. Evidence that glyceraldehyde-3-phosphate dehydrogenase is involved in age-induced apoptosis in mature cerebellar neurons in culture. J. Neurochem. 66:1996;928-935.
255. Yan G.-M., Lin S.-Z., Irwin R. P., Paul S. M. Activation of G proteins bidirectionally affects apoptosis of cultured cerebellar granule neurons. J. Neurochem. 65:1995;2425-2431.
256. Dessi F., Pollard H., Moreau J., Ben-Ari Y., Charriaut-Marlangue C. Cytosine arabinoside induces apoptosis in cerebellar neurons in culture. J. Neurochem. 64:1995;1980-1987.
257. 2+. Cell Death Differ. 4:1997;317-324.
258. Dudek H., Datta S. R., Franke T. F., Birnbaum M. J., Yao R., Cooper G. M., Segal R. A., Kaplan D. R., Greenberg M. E. Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science. 275:1997;661-663.
259. Müller W. E. G., Schröder H. C., Ushijima H., Dapper J., Bormann J. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: Prevention by memantine. Eur. J. Pharmacol. 226:1992;209-214.
260. Koh J.-Z., Wie M. B., Gwag B. J., Sensi S. L., Canzoniero L. M. T., Demaro J., Csernansky C., Choi D. W. Staurosporine-induced neuronal apoptosis. Exp. Neurol. 135:1995;153-159.
261. Ratan R. R., Murphy T. H., Baraban J. M. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:1994;376-379.
262. Loo D. T., Copani A., Pike C. J., Whittemore E. R., Walencewicz A. J., Cotman C. W. Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. Proc. Natl. Acad. Sci. USA. 90:1993;7951-7955.
263. Müller W. E. G., Romero F. J., Perovic S., Pergande G., Pialoglou P. Protection of flupirtine on beta-amyloid-induced apoptosis in neuronal cells in vitro: Prevention of amyloid-induced glutathione depeletion. J. Neurochem. 68:1997;2371-2377.
264. Newell D. W., Hsu S. S., Papermaster V., Malouf A. T. Colchicine is selectively neurotoxic to dentate granule cells in organotypic cultures of rat hippocampus. NeuroToxicology. 14:1993;375-381.
265. Forloni G., Angeretti N., Chiesa R., Monzani E., Salmona M., Bugiani O., Tagliavini F. Neurotoxicity of a prion protein fragment. Nature. 362:1993;543-546.
266. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
267. Watt J. A., Pike C. J., Walencewicz-Wasserman A. J., Cotman C. W. Ultrastructural analysis of beta-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res. 661:1994;147-156.
268. +. Neurosci. Lett. 170:1994;191-194.
269. Brugg B., Michel P. P., Agid Y., Ruberg M. Ceramide induces apoptosis in cultured mesencephalic neurons. J. Neurochem. 66:1996;733-739.
270. Middleton G., Nunez G., Davies A. M. Bax promotes neuronal survival and antagonises the survival effects of neurotrophic factors. Development. 122:1996;695-701.
271. Sadoul R., Fernandez P.-A., Quiquerez A.-L., Martinou I., Maki M., Schröter M., Becherer J. D., Irmler M., Tschopp J., Martinou J.-C. Involvement of the proteasome in the programmed cell death of NGF-deprived sympathetic neurons. EMBO J. 15:1996;3845-3852.
272. Ito A., Horigome K. Ceramide prevents neuronal programmed cell death induced by nerve growth factor deprivation. J. Neurochem. 65:1995;463-466.
273. Martinou I., Fernandez P.-A., Missotten M., White E., Allet B., Sadoul R., Martinou J.-C. Viral proteins E1B19K and p35 protect sympathetic neurons from cell death induced by NGF deprivation. J. Cell. Biol. 128:1995;201-208.
274. Freeman R. S., Estus S., Johnson E. M. Analysis of cell-cycle-related gene expression in postmitotic neurons: Selective induction of cyclin D1 during programmed cell death. Neuron. 12:1994;343-355.
275. Martin D. P., Schmidt R. E., DiStefano P. S., Lowry O. H., Carter J. G., Johnson E. M. Inhibitors of protein synthesis and RNA synthesis prevent neuronal death caused by nerve growth factor deprivation. J. Cell. Biol. 106:1988;829-844.
276. 2+. J. Neurosci. 15:1995;643-664.
277. Héron A., Pollard H., Dessi F., Moreau J., Lasbennes F., Ben-Ari Y., Charriaut-Marlangue C. Regional variability in DNA fragmentation after global ischemia evidenced by combined histological and gel electrophoresis observations in the rat brain. J. Neurochem. 61:1993;1973-1976.
278. Islam N., Aftabuddin M., Moriwaki A., Hori Y. Detection of DNA damage induced by apoptosis in the rat brain following incomplete ischemia. Neurosci. Lett. 188:1995;159-162.
279. Nitatori T., Sato N., Waguri S., Karasawa Y., Araki H., Shibanai K., Kominami E., Uchiyama Y. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J. Neurosci. 15:1995;1001-1011.
280. Linnik M. D., Zahos P., Geschwind M. D., Federoff H. J. Expression of bcl-2 from a defective herpes simplex virus-1 vector limits neuronal death in focal cerebral ischemia. Stroke. 26:1995;1670-1675.
281. Pollard H., Cantagrel S., Charriaut-Marlangue C., Moreau J., Ari Y. B. Apoptosis associated DNA fragmentation in epileptic brain damage. NeuroReport. 5:1994;1053-1055.
282. French L. E., Hahne M., Viard I., Radlgruber G., Zanone R., Becker K., Müller C., Tschopp J. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover. J. Cell. Biol. 133:1996;335-343.
283. Garcia-Venezuela E., Shareef S., Walsh J., Sharma S. C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 61:1995;33-44.
284. Hafezi F., Steinbach J. P., Marti A., Munz K., Wang Z.-Q., Wagner E. F., Aguzzi A., Reme C. E. The absence of c-fos prevents light-induced apoptotic cell death of photoreceptors in retinal degeneration in vivo. Nature Med. 3:1997;346-349.
285. Nucci C., Piccirilli S., Bagetta G., Nisticò G., Cerulli L. ND. Neurosci. Lett. 229:1997;185-188.
286. Nucci C., Piccirilli S., Palma E., Bagetta G., Nistico G., Cerulli L. NL. NeuroReport. 7:1996;2863-2866.
287. Chang G.-Q., Hao Y., Wong F. Apoptosis: Final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron. 11:1993;595-605.
288. Giese A., Groschup M. H., Hess B., Kretzschmar H. A. Neuronal cell death in scrapie-infected mice is due to apoptosis. Brain Pathol. 5:1995;213-221.
289. Bagetta G., Corasaniti T., Berliocchi L., Navarra M., Finazzi-Agró A., Nisticó G. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem. Biophys. Res. Commun. 211:1995;130-136.
290. Bagetta G., Corasaniti M. T., Malorni W., Rainaldi G., Berliocchi L., Finazzi-Agrò A., Nistico G. The HIV-1 gp120 causes ultrastructural changes typical to apoptosis in the rat cerebral cortex. NeuroReport. 7:1996;1722-1724.
291. New D. R., Ma M., Epstein L. G., Nath A., Gelbard H. A. Human immunodeficiency virus type 1 Tat protein induces death by apoptosis in primary human neuron cultures. J. Neurovirol. 3:1997;168-173.
292. Wood K. A., Youle R. J. The role of free radicals and p53 in neuron apoptosis in vivo. J. Neurosci. 15:1995;5851-5857.
293. Dragunow M., Faull R. L. M., Lawlor P., Beilharz E. J., Singleton K., Walker E. B., Mee E. In situ evidence for DNA fragmentation in Huntington's disease striatum and Alzheimer's disease temporal lobes. NeuroReport. 6:1995;1053-1057.
294. Thomas L. B., Gates D. J., Richfield E. K., O'Brien T. F., Schweitzer J. B., Steindler D. A. DNA end labeling (Tunel) in Huntington's disease and other neuropathological conditions. Exp. Neurol. 133:1995;265-272.
295. Smale G., Nichols N. R., Brady D. R., Finch C. E., Horton W. E. Jr. Evidence for apoptotic cell death in Alzheimer's disease. Exp. Neurol. 133:1995;225-230.
296. Su J. H., Anderson A. J., Cummings B. J., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
297. Gelbard H. A., James H. J., Sharer L. R., Perry S. W., Saito Y., Kazee A. M., Blumberg B. M., Epstein L. G. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropathol. Appl. Neurobiol. 21:1995;208-217.
298. Adle-Biassette H., Levy Y., Colombel M., Poron F., Natchev S., Keohane C., Gray F. Neuronal apoptosis in HIV infection in adults. Neuropathol. Appl. Neurobiol. 21:1995;218-227.
299. Petito C. K., Roberts B. Evidence of apoptotic cell death in HIV encephalitis. Am. J. Pathol. 146:1995;1121-1130.
300. Anglade P., Vyas S., Javoy-Agid F., Herrero M. T., Michel P. P., Marquez J., Mouatt-Prigent A., Ruberg M., Hirsch E. C., Agid Y. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease. Histol. Histopathol. 12:1997;25-31.
301. Rosomoff H. L., Kochanek P. M., Clark R., DeKosky S. T., Ebmeyer U., Grenvik A. N., Marion D. W., Obrist W., Palmer A. M., Safer P., White R. J. Resuscitation from severe brain trauma. Crit. Care Med. 24:1996;S48-S56.
302. McQuaid S., McMahon J., Herron B., Cosby S. L. Apoptosis in measles virus-infected human central nervous system tissues. Neuropathol. Appl. Neurobiol. 23:1997;218-224.
303. Lucas M., Izquierdo G., Munoz C., Solano F. Internucleosomal breakdown of the DNA of brain cortex in human spongiform encephalopathy. Neurochem. Int. 31:1997;241-244.